1 – 8 of 8
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
Novel coagulation factor concentrates: Issues relating to their clinical implementation and pharmacokinetic assessment for optimal prophylaxis in haemophilia patients.
(
- Contribution to journal › Scientific review
- 2011
-
Mark
The need for speed in the management of haemophilia patients with inhibitors
(
- Contribution to journal › Article
-
Mark
PET imaging of patients with non-small cell lung cancer employing an EGF receptor targeting drug as tracer
(
- Contribution to journal › Article
- 2008
-
Mark
Determination of ivermectin and transformation products in environmental waters using hollow fibre-supported liquid membrane extraction and liquid chromatography-mass spectrometry/mass spectrometry
(
- Contribution to journal › Article
- 2006
-
Mark
The relation between survival and expression of HER1 and HER2 depends on the expression of HER3 and HER4 : a study in bladder cancer patients
(
- Contribution to journal › Article
- 2004
-
Mark
Expression of HER3, HER4 and their ligand heregulin-4 is associated with better survival in bladder cancer patients
(
- Contribution to journal › Article
- 1995
-
Mark
Navoban (tropisetron) alone and in combination with dexamethasone in the prevention of chemotherapy-induced nausea and vomiting : the Nordic experience. The Nordic Antiemetic Trial Group
(
- Contribution to journal › Article
- 1994
-
Mark
A randomized, multicenter study comparing the efficacy and tolerability of tropisetron, a new 5-HT3 receptor antagonist, with a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesis
(
- Contribution to journal › Article